Roger J. Pomerantz, MD, FACP in

Roger J. Pomerantz, MD, FACP

Login to view DISC.
Member Board of Directors at 1E Therapeutics
📍 New York City Metropolitan Area, United States

Roger serves on multiple biotech boards, leveraging his expertise in infectious diseases. With a background from Harvard Medical School and MIT, he has led the development of 14 approved drugs for HIV, HCV, and TB, and has completed over 160 business development and licensing deals in leadership roles at Merck and Johnson & Johnson.

He played a pivotal role in developing some of the first successful treatments for both HIV and Hepatitis C, fundamentally changing the course of those diseases.

Read the full overview →
Experience
11 Years
Current Role
Member Board of Directors
Location
New York City Metropolitan Area, United States
Personality Overview

How Roger shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Roger cares about

Infectious Disease Cures
His entire career has focused on developing novel treatments for diseases like HIV, HCV, and C. diff, holding global head of infectious disease roles at Merck and J&J.
Biotech Board Leadership
Serves as Chairman or board member for numerous public biotech companies, including Indaptus Therapeutics, CollPlan, Viracta, and 1E Therapeutics, guiding their strategic direction.
+5 more topics Login to view topics
Career

Work history

4-2025
Member Board of Directors
1E Therapeutics
8-2021
Founding Chairman of the Board of Directors
Indaptus Therapeutics Inc.
2-2020
Chairman Of The Board Of Directors
CollPlant
12-2019
Senior Clinical Advisor to the Board of Directors
Seres Therapeutics
9-2013 - 12-2019
Founding Chairman of the Board of Directors
Seres Therapeutics
In the press

Media appearances

CollPlant Announces Appointment of Roger J. Pomerantz, M.D.. Featured in CollPlant
See now
Education
1987 - 1988
Chief Resident
Harvard Medical School - Massachusetts General Hospital
1988 - 1990
Post Doctoral Fellowship - Whitehead Institute of Biomedical Research of MIT
Massachusetts Institute of Technology
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Ainara Martin
Ainara Martin
Head of Luxury Southern Europe - Marketing
Diageo
 Megan Sirockman
Megan Sirockman
Global Head of Marketing & Product, Portfolio Platforms
Diageo
 Sarah Shimmons
Sarah Shimmons
Board Member
The Drinks Association
 Joanna Segesser
Joanna Segesser
Global Head of Marketing Capability (LPL)
Diageo
Unlock the full playbookSee exactly how to sell to Roger. Free, 10 seconds.